Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 505

1.

Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting.

Koch CG, Li L, Duncan AI, Mihaljevic T, Cosgrove DM, Loop FD, Starr NJ, Blackstone EH.

Crit Care Med. 2006 Jun;34(6):1608-16.

PMID:
16607235
2.

Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery.

Kuduvalli M, Oo AY, Newall N, Grayson AD, Jackson M, Desmond MJ, Fabri BM, Rashid A.

Eur J Cardiothorac Surg. 2005 Apr;27(4):592-8.

PMID:
15784356
3.

Risk factors for red blood cell transfusion after coronary artery bypass graft surgery.

van Straten AH, Kats S, Bekker MW, Verstappen F, ter Woorst JF, van Zundert AJ, Soliman Hamad MA.

J Cardiothorac Vasc Anesth. 2010 Jun;24(3):413-7. doi: 10.1053/j.jvca.2010.01.001. Epub 2010 Mar 15.

PMID:
20231104
4.

Octogenarians undergoing coronary artery bypass graft surgery: resource utilization, postoperative mortality, and morbidity.

Scott BH, Seifert FC, Grimson R, Glass PS.

J Cardiothorac Vasc Anesth. 2005 Oct;19(5):583-8.

PMID:
16202890
5.

Obesity is associated with increased morbidity after coronary artery bypass graft surgery in patients with renal insufficiency.

Tolpin DA, Collard CD, Lee VV, Elayda MA, Pan W.

J Thorac Cardiovasc Surg. 2009 Oct;138(4):873-9. doi: 10.1016/j.jtcvs.2009.02.019. Epub 2009 Apr 8.

6.

Clopidogrel treatment before coronary artery bypass graft surgery increases postoperative morbidity and blood product requirements.

Filsoufi F, Rahmanian PB, Castillo JG, Kahn RA, Fischer G, Adams DH.

J Cardiothorac Vasc Anesth. 2008 Feb;22(1):60-6. doi: 10.1053/j.jvca.2007.10.009. Epub 2007 Dec 31.

PMID:
18249332
7.

Impact of prior percutaneous coronary intervention on the outcome of coronary artery bypass surgery: a multicenter analysis.

Massoudy P, Thielmann M, Lehmann N, Marr A, Kleikamp G, Maleszka A, Zittermann A, Körfer R, Radu M, Krian A, Litmathe J, Gams E, Sezer O, Scheld H, Schiller W, Welz A, Dohmen G, Autschbach R, Slottosch I, Wahlers T, Neuhäuser M, Jöckel KH, Jakob H.

J Thorac Cardiovasc Surg. 2009 Apr;137(4):840-5. doi: 10.1016/j.jtcvs.2008.09.005. Epub 2009 Jan 18.

8.

Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.

Collard CD, Body SC, Shernan SK, Wang S, Mangano DT; Multicenter Study of Perioperative Ischemia (MCSPI) Research Group, Inc; Ischemia Research and Education Foundation (IREF) Investigators.

J Thorac Cardiovasc Surg. 2006 Aug;132(2):392-400.

9.

The effect on long-term survival of erythrocyte transfusion given for cardiac valve operations.

Engoren M, Habib RH, Hadaway J, Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah A.

Ann Thorac Surg. 2009 Jul;88(1):95-100, 100.e1-3. doi: 10.1016/j.athoracsur.2009.04.047.

PMID:
19559202
10.

Transfusion in coronary artery bypass grafting is associated with reduced long-term survival.

Koch CG, Li L, Duncan AI, Mihaljevic T, Loop FD, Starr NJ, Blackstone EH.

Ann Thorac Surg. 2006 May;81(5):1650-7.

PMID:
16631651
11.

Leukoreduction program for red blood cell transfusions in coronary surgery: association with reduced acute kidney injury and in-hospital mortality.

Romano G, Mastroianni C, Bancone C, Della Corte A, Galdieri N, Nappi G, De Santo LS.

J Thorac Cardiovasc Surg. 2010 Jul;140(1):188-95. doi: 10.1016/j.jtcvs.2010.03.022. Epub 2010 Apr 22.

12.

Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting.

Bybee KA, Powell BD, Valeti U, Rosales AG, Kopecky SL, Mullany C, Wright RS.

Circulation. 2005 Aug 30;112(9 Suppl):I286-92.

13.

Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data.

Weiss ES, Chang DD, Joyce DL, Nwakanma LU, Yuh DD.

J Thorac Cardiovasc Surg. 2008 Mar;135(3):503-11, 511.e1-3. doi: 10.1016/j.jtcvs.2007.10.042. Epub 2008 Feb 21.

14.

Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation.

Koch CG, Li L, Van Wagoner DR, Duncan AI, Gillinov AM, Blackstone EH.

Ann Thorac Surg. 2006 Nov;82(5):1747-56.

PMID:
17062241
15.

Platelet transfusion in cardiac surgery does not confer increased risk for adverse morbid outcomes.

McGrath T, Koch CG, Xu M, Li L, Mihaljevic T, Figueroa P, Blackstone EH.

Ann Thorac Surg. 2008 Aug;86(2):543-53. doi: 10.1016/j.athoracsur.2008.04.051.

PMID:
18640332
16.

Obesity in diabetic patients undergoing coronary artery bypass graft surgery is associated with increased postoperative morbidity.

Pan W, Hindler K, Lee VV, Vaughn WK, Collard CD.

Anesthesiology. 2006 Mar;104(3):441-7.

PMID:
16508390
17.

Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery.

Thielmann M, Neuhäuser M, Marr A, Jaeger BR, Wendt D, Schuetze B, Kamler M, Massoudy P, Erbel R, Jakob H.

J Thorac Cardiovasc Surg. 2007 Nov;134(5):1143-9.

18.

Intraoperative red blood cell transfusion during coronary artery bypass graft surgery increases the risk of postoperative low-output heart failure.

Surgenor SD, DeFoe GR, Fillinger MP, Likosky DS, Groom RC, Clark C, Helm RE, Kramer RS, Leavitt BJ, Klemperer JD, Krumholz CF, Westbrook BM, Galatis DJ, Frumiento C, Ross CS, Olmstead EM, O'Connor GT.

Circulation. 2006 Jul 4;114(1 Suppl):I43-8.

19.

Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache?

Kapetanakis EI, Medlam DA, Boyce SW, Haile E, Hill PC, Dullum MK, Bafi AS, Petro KR, Corso PJ.

Eur Heart J. 2005 Mar;26(6):576-83. Epub 2005 Feb 21.

PMID:
15723815
20.

Effect of complications on mortality after coronary artery bypass grafting surgery: evidence from New York State.

Glance LG, Osler TM, Mukamel DB, Dick AW.

J Thorac Cardiovasc Surg. 2007 Jul;134(1):53-8.

Supplemental Content

Support Center